Format

Send to

Choose Destination
J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14192. [Epub ahead of print]

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.

Author information

1
McMaster University, Hamilton, Canada.
2
American University of Beirut, Beirut, Lebanon.
3
University of Ottawa, Ottawa, Canada.
4
University of Barcelona, Barcelona, Spain.
5
Insubria University, Insubria, Italy.
6
Weill Cornell Medicine College, New York, USA.
7
King's College London, London, UK.
8
Cochrane Germany, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
9
Hamilton Regional Laboratory Medicine Program, Hamilton, Canada.
10
Nationwide Children's Hospital, Columbus, USA.
11
University of Padova, Padua, Italy.
12
Hospital ClĂ­nic, Barcelona, Spain.
13
Oxford, UK.

Abstract

Background The McMaster RARE-Bestpractices project group selected the catastrophic antiphospholipid syndrome (CAPS) for a pilot exercise in guideline development for a rare disease. Objectives The objectives of this exercise were to provide a proof of principle that guidelines can be developed for rare diseases and assist in clinical decision making for CAPS. Patients/Methods The GIN-McMaster Guideline Development checklist and GRADE methodology were followed throughout the guideline process. The CAPS guideline was coordinated by a steering committee, and the guideline panel was formed with representation from all relevant stakeholder groups. Systematic reviews were performed for the key questions. To supplement the published evidence, we piloted novel methods, including use of an expert-based evidence elicitation process and ad hoc analysis of registry data. Results This paper describes the CAPS guideline recommendations, including evidence appraisal and discussion of special circumstances and implementation barriers identified by the panel. Many of these recommendations are conditional, because of subgroup considerations in this heterogeneous disease, as well as variability in patient values and preferences. Conclusions The CAPS clinical practice guideline initiative met the objective of the successful development of a clinical practice guideline in a rare disease using GRADE methodology. We expect that clinicians caring for patients with suspected CAPS will find the guideline useful in assisting with diagnosis and management of this rare disease.

KEYWORDS:

antibodies, antiphospholipid; antiphospholipid syndrome; practice guideline; rare diseases; thrombosis

PMID:
29978552
DOI:
10.1111/jth.14192

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center